FTXH vs. XHS
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and XHS (SPDR S&P Health Care Services ETF) are both Health & Biotech Equities funds - FTXH tracks the Nasdaq U.S. Smart Pharmaceuticals Index while XHS tracks the S&P Health Care Services Select Industry Index. Both are passively managed. Over the past 5 years, FTXH returned 9.96%/yr vs 4.53%/yr for XHS. A 0.55 correlation means they provide meaningful diversification when combined. FTXH charges 0.60%/yr vs 0.35%/yr for XHS.
Performance
FTXH vs. XHS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FTXH achieves a 17.45% return, which is significantly lower than XHS's 26.76% return.
FTXH
- 1D
- 1.59%
- 1M
- 8.29%
- 6M
- 15.60%
- YTD
- 17.45%
- 1Y
- 48.05%
- 3Y*
- 15.75%
- 5Y*
- 9.96%
- 10Y*
- —
XHS
- 1D
- 0.45%
- 1M
- 10.64%
- 6M
- 21.53%
- YTD
- 26.76%
- 1Y
- 45.58%
- 3Y*
- 13.33%
- 5Y*
- 4.53%
- 10Y*
- 9.10%
FTXH vs. XHS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 17.45% | 24.15% | 2.98% | -1.41% | 2.55% | 6.14% | 11.73% | 22.13% | -9.51% | 19.44% |
XHS SPDR S&P Health Care Services ETF | 26.76% | 18.83% | 1.76% | 5.15% | -19.87% | 9.76% | 33.66% | 18.81% | 1.96% | 17.65% |
Correlation
The correlation between FTXH and XHS is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.44 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.55 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.58 |
Correlation (All Time) Calculated using the full available price history since Sep 22, 2016 | 0.55 |
The correlation between FTXH and XHS shifts across timeframes, from 0.44 (1 year) to 0.58 (5 years), reflecting how their relationship changes across market environments.
FTXH vs. XHS - Sectors Allocation Comparison
Sectors
FTXH
XHS
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FTXH
XHS
Basic Materials
FTXH
-
XHS
-
Communication Services
FTXH
-
XHS
-
Consumer Cyclical
FTXH
-
XHS
-
Consumer Defensive
FTXH
-
XHS
-
Energy
FTXH
-
XHS
-
Financial Services
FTXH
-
XHS
Industrials
FTXH
-
XHS
Real Estate
FTXH
-
XHS
-
Technology
FTXH
-
XHS
-
Utilities
FTXH
-
XHS
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FTXH vs. XHS — Risk / Return Rank
FTXH
XHS
FTXH vs. XHS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and SPDR S&P Health Care Services ETF (XHS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FTXH | XHS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.21 | ||
| Sortino ratioReturn per unit of downside risk | +0.68 | ||
| Omega ratioGain probability vs. loss probability | 1.46 | 1.45 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 6.46 | 3.82 | +2.65 |
| Martin ratioReturn relative to average drawdown | 18.87 | 13.16 | +5.71 |
Loading charts...
Drawdowns
FTXH vs. XHS - Drawdown Comparison
The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum XHS drawdown of -39.32%. Use the drawdown chart below to compare losses from any high point for FTXH and XHS.
Loading charts...
Drawdown Indicators
| FTXH | XHS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.11% | -39.32% | +7.21% |
Max Drawdown (1Y)Largest decline over 1 year | -7.47% | -11.99% | +4.52% |
Max Drawdown (3Y)Largest decline over 3 years | -19.51% | -17.81% | -1.70% |
Max Drawdown (5Y)Largest decline over 5 years | -19.51% | -31.34% | +11.83% |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.32% | — |
Current DrawdownCurrent decline from peak | -2.35% | -1.72% | -0.63% |
Average DrawdownAverage peak-to-trough decline | -5.78% | -10.12% | +4.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.55% | 3.48% | -0.93% |
Volatility
FTXH vs. XHS - Volatility Comparison
First Trust Nasdaq Pharmaceuticals ETF (FTXH) has a higher volatility of 5.77% compared to SPDR S&P Health Care Services ETF (XHS) at 5.41%. This indicates that FTXH's price experiences larger fluctuations and is considered to be riskier than XHS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FTXH | XHS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.77% | 5.41% | +0.36% |
Volatility (6M)Calculated over the trailing 6-month period | 12.65% | 12.81% | -0.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.51% | 17.91% | -0.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.52% | 21.22% | -4.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.44% | 22.40% | -3.96% |
FTXH vs. XHS - Expense Ratio Comparison
FTXH has a 0.60% expense ratio, which is higher than XHS's 0.35% expense ratio.
Dividends
FTXH vs. XHS - Dividend Comparison
FTXH's dividend yield for the trailing twelve months is around 1.10%, more than XHS's 0.20% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.10% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% | 0.00% |
XHS SPDR S&P Health Care Services ETF | 0.20% | 0.27% | 0.38% | 0.23% | 0.19% | 0.20% | 0.23% | 2.37% | 0.34% | 0.22% | 0.28% | 0.93% |
Frequently Asked Questions
FTXH and XHS have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FTXH has higher volatility (5.77%) compared to XHS (5.41%). In terms of maximum drawdown, FTXH dropped -32.11% vs XHS's -39.32%.
On 5-year performance, FTXH leads with 9.96% vs 4.53% for XHS. On fees, XHS is cheaper at 0.35% per year. On volatility, XHS has been the lower-risk option at 5.41%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FTXH has performed better with a 9.96% return vs 4.53%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XHS is cheaper with a 0.35% expense ratio, compared with 0.60% for FTXH.
FTXH has the higher dividend yield at 1.10%, compared with 0.20% for XHS.
FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index, while XHS tracks S&P Health Care Services Select Industry Index. They also come from different issuers: First Trust and State Street. Their fees differ too: 0.60% for FTXH and 0.35% for XHS.
FTXH currently has the higher Sharpe Ratio (2.77 vs 2.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FTXH and XHS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer